LINC00364

Across TCGA pan-cancer cohorts, LINC00364 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC00364 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00364 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00364 expression acts as an unfavorable survival marker, although some lineages such as MESO and CESC show a favorable association.

LUAD, KICH, and ACC are the cancer types where LINC00364 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.322	0.578	<.001	153	view →
KICH	OS	Tertile	All	0.408	0.893	<.001	90	view →
ACC	DFS	Tertile	All	0.124	0.607	<.001	78	view →
UCEC	OS	Tertile	All	0.866	0.939	.001	78	view →
COAD	DFS	Tertile	All	0.468	0.798	.002	72	view →
KIRC	OS	Tertile	All	0.529	0.663	.002	53	view →
THCA	OS	Tertile	II,III,IV	0.920	0.990	<.001	39	view →
BRCA	OS	Tertile	IV	0.317	0.882	<.001	36	view →
LIHC	OS	Tertile	II,III,IV	0.343	0.718	<.001	33	view →
PAAD	OS	Tertile	II,III,IV	0.272	0.474	.003	32	view →
MESO	DFS	Tertile	All	0.671	0.350	.034	24	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC00364–LUAD (OS)

Open the LUAD breakdown →